MoneyWorks4Me

Guj. Themis Biosyn reports Profit after tax of Rs 0.00 Mln, in the March 2021 quarter

01 May 2021 Evaluate
Revenue showed a marginal decline at Rs. 0.00 millions. For the quarter ended March 2021, as compared to corresponding quarter of last year.The Company has posted about -100.00%  dip in net profit at Rs. 0.00  millions in the quarter ended March 2021,against Rs . 109.51 millions  million in the same period of last fiscal year.A decline of 0.00 millions was observed in the OP in the quarter ended March 2021 from 135.13 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202103 202003 % Var 202103 202003 % Var 202003 201903 % Var
Sales 0.00 263.52 0.00 672.65 851.23 -20.98 851.24 410.51 107.36
Other Income 0.00 2.87 0.00 24.71 17.05 44.93 17.04 22.14 -23.04
PBIDT 0.00 135.13 -100.00 344.95 335.41 2.84 335.42 95.47 251.34
Interest 0.00 3.02 0.00 6.89 9.23 -25.35 9.23 1.29 615.50
PBDT 0.00 132.11 -100.00 338.06 326.18 3.64 326.19 94.18 246.35
Depreciation 0.00 3.93 0.00 10.61 13.63 -22.16 13.62 12.21 11.55
PBT 0.00 128.18 -100.00 327.45 312.55 4.77 312.57 81.97 281.32
TAX 0.00 18.67 0.00 83.58 75.82 10.23 75.82 17.87 324.29
Deferred Tax 0.00 -1.62 0.00 0.58 -0.53 -209.43 -0.54 9.17 -105.89
PAT 0.00 109.51 -100.00 243.87 236.73 3.02 236.75 64.10 269.34
Equity 0.00 72.64 0.00 72.64 72.64 0.00 72.64 72.64 0.00
PBIDTM(%) 0.00 51.28 0.00 51.28 39.40 30.15 39.40 23.26 69.43
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..